An Extension Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer
Clinical trial NCT04151719 · WITHDRAWN
Trial details
- NCT number
- NCT04151719
- Sponsor
- Bausch Health Americas, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-03
- Primary completion
- 2024-02-03
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.